Skip to main content
ConductScienceScienceDex

Robert Thomas Manguso

FY2026 NIH rank #6,327
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11960504Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0003-1336-413XVerified identifier for this researcher
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$2.9M
Full award amounts, FY2026
Award Records
5
Records listing this PI
Award-Linked Rank
#6,327
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Robert Thomas Manguso. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$2.9M

5 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Robert Thomas Manguso as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA312510-01R01
    Unleashing IFN signal transduction to prime HNSCC immunogenicity
    Broad Institute, Inc.
    $742.4K
    award amount
  • 5R01CA292508-02R01
    Harnessing mutant IDH1 as a therapeutic target in liver cancer and other solid malignancies
    Massachusetts General Hospital
    $676.2K
    award amount
  • 5R01CA285582-02R01
    Investigating CREB5-driven mechanisms of immune therapy resistance
    Massachusetts General Hospital
    $610.5K
    award amount
  • 1R21CA309357-01A1R21
    High-throughput identification of transcription factors that enhance CAR T cell efficacy in solid tumors.
    Broad Institute, Inc.
    $439.7K
    award amount
  • 1R21CA304619-01A1R21
    Investigating serial killing by CD8+ T cells using the novel "kiss-of-death" intercellular labeling platform
    Massachusetts General Hospital
    $420.6K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Robert Thomas Manguso as a PI.

Massachusetts General Hospital
MA
$1.7M
3 grants
Broad Institute, Inc.
MA
$1.2M
2 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Massachusetts General Hospital
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    R01 Grant Holder
  5. 2026
    $2M Cumulative Funding
  6. 2026
    Entered Top 50% Nationally
    Ranked #6327
  7. 2026
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Robert Thomas Manguso.

Nabeel El-bardeesy
Massachusetts General Hospital
2
shared awards
William C. Hahn
Massachusetts General Hospital
2
shared awards
David A Barbie
Broad Institute, Inc.
1
shared award
Debattama Rai Sen
Massachusetts General Hospital
1
shared award

Explore further

Find collaborators for Robert Thomas Manguso

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →